LivaNova

Youtube Subscribe

Open: 51.0 Close: 48.67 Change: -2.33

Are you looking for information about LivaNova? We programmed an AI to summarize it for you.

Are looking for the most relevant information about LivaNova? Investor spend a lot of time searching for information to make investment decisions in LivaNova. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about LivaNova are: PLC, LivaNova, report, LIVN, Q3, Earnings, rating, and the most common words in the summary are: livanova, stock, plc, company, buy, earnings, best, . One of the sentences in the summary was: LivaNova PLC has an average rating of “Hold” and a consensus price target of …

Concept Map

Semantic Network

Stock Summary

LivaNova PLC designs, develops, manufactures, and sells therapeutic solutions. The Cardiopulmonary segment develops, produces, and markets cardiopul pulmonary products. Neuromodulation segment designs, markets VNS Therapy.

Today's Summary

LivaNova PLC has an average rating of “Hold” and a consensus price target of $62.86. TheStreet upgraded LIVN from a “d+” rating to a ‘c-” in a research report.

Today's News

LivaNova: Q3 Earnings Snapshot The A.V. reports a loss of $7.3 million in its third quarter. LIVN expects full-year earnings in the range of $2.60 to $2.80 per share. LivaNova PLC has an average rating of “Hold” and a consensus price target of $62.86. TheStreet upgraded LIVN from a “d+” rating to a ‘c-” in a research report on Monday, July 17th. LivaNova PLC (U.K.) GlaxoSmithKline PLC. (U.: GlaxOSmithKlines PLC) Eisai Co. (U: Liva Niva PLC). LivaVova reports third-quarter 2023. LivaNova PLC (NASDAQ:LIVN) Q3 2023 Earnings Call Transcript published on November 2, 2023 at 2:48 pm by Insider Monkey Transcripts in News , Transcripts. In the year 2022, LIVN had annual revenue of $1.02B, a decrease of -1.31%.

Stock Profile

"LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. It also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom."

Keywords

This document will help you to evaluate LivaNova without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about LivaNova are: PLC, LivaNova, report, LIVN, Q3, Earnings, rating, and the most common words in the summary are: livanova, stock, plc, company, buy, earnings, best, . One of the sentences in the summary was: LivaNova PLC has an average rating of “Hold” and a consensus price target of $62.86. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #livanova #stock #plc #company #buy #earnings #best.

Read more →

Youtube Subscribe

---